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Gas Chromatography Mass Spectrometry Assay 
for Ketamine and its Metabolites in Plasma 
Serrine S. L a d  and Edward F. DorninoS 
Department of Pharmacology, The University of Michigan, Ann Arbor, Michigan 48109, U.S.A. 
A highly sensitive and specific method for quantitation of ketamine and two of its metabolites found in monkey, 
dog and human plasma was developed using a gas chromatography selected ion monitoring assay operated in 
both electron impact and chemical ionization modes. This technique yields excellent precision, reproducibiiity 
and accuracy. From 1 ng to 3 pg of ketamine or its metabolites in 1 ml of plasma can be detected. The technique 
of electron capture gas chromatography is compared. AU three assays were found to be quite useful but the gas 
chromatography mass spectrometry techniques were more specific. 
INTRODUCTION 
Earlier studies for the assay of ketamine 2-(o-chloro- 
phenyl)-2-(methylamino)-cyclohexanone HCl (1) have 
been carried out with fluorimetry' and gas 
chr~matography.~-~ Although the latter technique pro- 
vides sufficient sensitivity for routine clinical use, unde- 
sirable interference sometimes occur, particularly with 
flame ionization when the size of biological samples is 
limited or when the drug concentration is very low. 
It is our purpose to develop a sensitive, selective and 
specific method of quantitative analysis of ketamine and 
its metabolites in plasma, a suitable assay for plasma 
samples which have widely varying drug levels that could 
be used in pharmacokinetic studies. A significant 
increase in sensitivity and specificity of detection using a 
gas chromatograph mass spectrometry computer system 
(g.c.m.s. com.) was achieved in the assay reported 
herein. 
EXPERIMENTAL 
Extraction and derivatization 
The extraction and derivatization of ketamine (1) was 
that of Chang and Glazko.2 The flow diagram of the 
procedure is shown in Fig. 1. CL-394, the o-Br analog 
(2) of ketamine, was used as the internal standard. 
Ketamine, CL-394 and ketamine metabolites were pro- 
vided generously by Dr A. J. Glazko, Parke, Davis and 
Co., Ann Arbor, Michigan. Heptafluorobutyric anhy- 
dride was obtained in 1 ml ampules or a 25 g bottle from 
Pierce Chemical Co., Rockford, Illinois. 'Nanograde' 
solvents were obtained from Mallinckrodt Chemical 
Works, St Louis, Missouri. The column packing, 3% 
OV-17 on 100/120 Gas Chrom Q, was obtained from 
i- Predoctoral Fellow, Barbour Scholarship, Rackham School of 
$ To whom all correspondence should be directed. 
Graduate Studies. 
@Heyden & Son Ltd, 1977 
Applied Science Laboratories, Inc., State College, 
Pennsylvania. 
Analysis 
Quantitative analyses were made on two different 
instruments. The first was a Finnigan 3200 g.c.m.s. com. 
system operated in electron impact ( e i )  and chemical 
ionization (c.i.) modes and the second a Hewlett- 
Packard 76 10A gas chromatograph equipped with an 
electron capture detector of Ni63. For the analysis with 
the Finnigan a 5 ft X 2 mm glass U-tube column packed 
with 3% OV-17 on 100/120 mesh on Gas-Chrom Q was 
conditioned by heating overnight at 250 "C. The g.c. 
conditions were: column temperature 180 "C isother- 
mal, injector temperature 210 "C. In g.c.m.s.e.i. the 
electron energy was 25 or 70 eV. The carrier gas flow 
(He) was 20 ml min-l. The glass jet separator tempera- 
ture was 210 "C. In g.c.m.s.c.i. the reactant gas methane 
was run at 380 microns pressure. Electron energy was 
70 eV. The Hewlett-Packard was equipped with an 
automatic integrater. Column size was 6 ft X 4 mm U- 
tube glass column packed with 3% OV-17. Argon+ 
methane (95 : 5)  gas was used as the carrier gas. The unit 
was operated isothermally at 175 "C with the detector 
maintained at 250 "C. 
RESULTS AND DISCUSSION 
The metabolic products of ketamine were first identified 
in plasma, urine and bile by Glazko and Chang.5r6 Both 
ketamine metabolite l a  and ketamine metabolite l b  can 
be detected in small amounts in plasma after ketamine 
administration.2 The structures of the derivatized com- 
pounds are shown in Fig. 4. The extraction and derivati- 
zation procedure for ketamine and its metabolites from 
dog, monkey and human plasma provided excellent gas 
chromatographic separation. Derivatization was neces- 
sary since without it both ketamine (1) and CL-394 (2) 
showed peaks with small shoulders when run in a gas 
chromatograph with a flame ionization detector. How- 
ever, after derivatization, sharp and symmetrical peaks 
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Ketamine 
0-1Opg in EtAc (lOOngpI-') added to plasma 
EtAc evaporated under N, 
1 ml of plasma added followed by 
5 p g  of CL-394 in 1 ml of 0.1 N HCI (internal standard); 0.1 ml of borax buffer (10% Na2B407 in 5 N NaOH), mix 
2 ml of benzene 
I 
1 
shake for 10 min at 80-100 oscillations min-' in automatic shaker 
centrifuge, 3500 rev min-' (15 min) I .  
Clean up 
i L 
discard benzene layer 
aqueous 
layer 
dry with anhydrous Na2S04, approx. 1 g, centrifuge: 3500 rev min-', transfer to a 3.5 ml vial 
prewashed with MeOH with Teflon screw cap to avoid contamination. I add the following: 
1 O O p l  of heptafluorobutyric anhydride and 
1 O O p l  of pyridine (dried over KOH pellets) added with Hamilton syringe 
vortex 
heat at 75 "C for 1 h on heating block 
cool to room temperature, transfer to a centrifuge tube 
I 
1 
L shake 5 min at 220-250 oscillations min-' in automatic shaker, centrifuge, 3500 rev min-' wash with 2 ml of 0.5 N NaOH 
discard benzene layer 
aqueous wash with 2 ml of 0.25 N HCI 
layer 
shake 5 min at 220-250 oscillations min-' in an automatic shaker, centrifuge, 3500 rev min-' 
discard 
aqueous 
layer 
benzene layer 
dry with anhydrous Na2S04 (1 g) 
centrifuge at 3500 rev min-', transfer to a 3.5 ml vial 
-i 
I 
I 
dry benzene layer was evaporated under NZ, residue dissolved in 20-5Opl of EtAc. 
Analysis g.c.m.s. analysis (1-2pl) 
Figure 1. Flow diagram for the extraction and derivatization of ketamine and metabolites in plasma (after Chang and Glazko'). 
were obtained. Ketamine metabolites l a  and lb,  which 
are primary amines, are also extracted and derivatized 
with the same procedure so all three compounds can be 
detected in a single plasma sample. A typical total ion 
chromatogram with approximately 100 ng of 1, la ,  l b  
and 2 extracted from monkey plasma is shown in Fig. 2. 
Similar chromatograms were obtained with either e.i. 
(using an electron energy of 25eV) or c.i. (using 
methane at a pressure of 380 microns). The mass spectra 
of the heptafluorobutyryl derivatives are illustrated in 
Figs 3 and 4 in both modes. Part of the spectra were 
multiplied as shown in order to better indicate the small 
intensity ions. Small molecular ions [MI+ as well as the 
characteristic C1 and Br isotope ions [M+2]+ were 
obtained in the e.i. spectra of 1,2 and lb .  No molecular 
ion was obtained for l a  but a m/e 384 for the fragment 
[M-Cl]+ was present. The intensity of the molecular 
ions was reduced when the mass spectrometer was oper- 
ated at electron energies of 70 eV. As might be expected 
because of their similar structures, 1 and 2 show corres- 
ponding e.i. spectra. All the quantitative analyses using 
selected ion monitoring were carried out with the mass 
spectrometer operated at electron energy of 70 eV since 
the mass fragments rather than molecular ions were 
monitored selectively. The fragment m/e 210 was the 
base peak for 1 and 2. The conjugate double bond in l b  
apparently stabilizes the molecule for very few frag- 
ments are seen in its spectrum. Postulated structures of 
the major fragments are shown in Tables 1 and 2. 
Spectra obtained in the c.i. mode using methane as the 
reactant gas at 380 microns pressure gave the 
quasimolecular ions [M + H]+ of all four compounds as 
the base peaks. Other ion species such as [M+C,H,]' 
and [M+ C3H5]+ were also obtained. Characteristic m/e 
205, 207 and 251 ions corresponded to the loss of the 
heptafluorobutyryl amine group. For quantitative pur- 
poses, selected ion monitoring was used with m/e 210 
for 1 and 2 and m/e 102 for both metabolites under e.i. 
condition. The quasimolecular ions [M+H]+ of the 
compounds (m/e 418, 420, 434, 478) or the major 
fragments m/e 205, 207, 251 were selectively moni- 
tored in the c.i. mode. 
CL-394 (3 pg) (internal standard) was added to mon- 
key plasma (1 ml) containing known amounts of 1, l a  
and l b  and extracted and derivatized as described in Fig. 
1. Aliquots of the (1-2 pl) sample were analyzed. Each 
sample was analysed twice and the two peak area ratios 
averaged. Standard curves of peak area ratio under e.i. 
conditions were linear and passed through the origin for 
all three compounds (Fig. 5). The ratio of fragment m/e 
210/210 was used for 1 and 102/102 for both l a  and lb .  
Similar linearity was obtained using c.i., as shown in Fig. 
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I a: 2.5 min 
d I b: 2.83 min 
50 too 
Scan no. 
Figure 2. Total ion chromatogram of the heptafluorobutyryl 
derivatives of ketamine (I), ketamine metabolite la ,  ketamine 
metabolite I b  and the o-Br analog (2) of ketamine as internal 
standard (is.). The g.c.m.s. conditions are as follows: column: 
3% OV-17; solution: ethyl acetate; column temp.: 170°C; 
separator temp.: 210°C; helium flow: 20 ml/min-'. A total of 
5 fig ml-' of each was added to monkey plasma. The extracted 
and derivatized products were then injected as 100 ng pi-' of the 
final extract. Note the minor peaks in the total ion chromatogram 
which are also present in extracts of control plasma. No interfer- 
ence was noted, however, in the mass fragmentograms. 
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Figure 3. Mass spectra of the heptafluorobutyryl derivatives of 
ketamine (1) and its o-Br analog (2) in e.i. (a and b) and c.i. (c and 
d) modes. Operating conditions for data of this and the subse- 
quent figures are given in the text under Analysis. 
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Figure 4. Mass spectra of the heptafluorobutyryl derivatives of 
ketamine metabolites l a  and I b  in e.i. (a and b) and c.i. (c and d) 
modes. Conditions are as described in the legend of Fig. 2. 
6. The analysis of ketamine and its two metabolites by 
selected ion monitoring is shown in Fig. 7. The ions 
monitored were m/e 210 for 1 and 2 and m/e 102 for 
the metabolites. Ions m/e 356 and m/e 3 14 for l a  and 
l b  were also monitored for identification purposes. The 
specificity of this technique is exemplified by the lack of 
contamination in the background spectrum and the 
presence of characteristic fragment peaks (Figs. 7 and 8). 
Similar results to those found with monkey plasma in 
both the e.i. and c.i. modes were obtained also from dog 
and human plasma extractions to which 1,2, la ,  and l b  
were added in varying amounts. 
c I 
Standard (pq rnt? 
Figure 5. Standard calibration curve for 1, la ,  and l b  in monkey 
plasma using electron impact selected ion recording. The inter- 
nal standard (2) was 3 pg  ml-' of plasma, while the ketamine and 
its metabolites were varied as shown. Of the final extracted 
volume of 20~1 ,  1pI of sample was injected. Hence, the total 
amount added was 1/20 of the total amounts shown. A total of 
25 ng can very easily be detected. About 1 ng is a reasonable limit 
of sensitivity. 
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Table 1. Postulated structures of e.i. mass fragments of Table 2. Postulated structures of e.i. mass fragments of 
ketamine metabolite l a  and ketamine metabolite l b  ketamiue (1) and its o-Br analog (2)" 
[ M  -28]+(M -CO) 
2 HFB 1 HFB 
mle mle 
477 433 
479 435 
405 
.~ 449 
CH COC,F7 +=+ / 
F! 
[ M  - 28-X]+ 
(M -CO-CI) 
[ M - 197]+ 
(M-COCaF,) 
[ M  - 1 88 - XI? 
( M  - C9H70F3X) 
H,C 0 F F 
I I I I I  
210 
l a  HFB 
m/e 
419 
(not shown in 
spectrum) 
42 1 
(not shown in 
spectrum) 
[M-351+ 384 
(M-CI) 
H COC,F7 
\ /  
,N 
[M-791' 340 
( M  -C2H40 - CI) 
X CH=CH-CH, 1 '  
196 152 
H COC,F, 
\ /  
+ 
C=CH, 
102 102 a 
- 69 69 
a X = CI (1); X = Br (2). 
The present g.c.m.s. assays were compared with the 
g.c. electron capture (g.c.e.c.) assay of Chang and 
Glazko.* Our results are in complete agreement. How- 
ever, a problem arises when dealing with a limited 
volume of plasma with an unknown amount of 
115 
CH3 * / 
l b  HFB 
m/e 
41 7 
41 9 
382 
- 
- 
314 
- 
115 
102 
- 
68 
ketamine. Under these circumstances it may not be 
possible to add the correct amount of internal standard 
to obtained reasonable proportional peak heights. Dis- 
proportionate peaks are more difficult to analyze with 
g.c.e.c. without a computer, in contrast to the use of a 
computer capable of normalizing the data. The specifi- 
city of g.c.m.s. in both the e.i. andespecially thec.i. modes 
remains a distinct advantage, especially when sample 
amounts are limited. As shown in the figures, g.c.m.s. 
sensitivity was quite good but not much better than that 
achieved by g.c.e.c. The use of g.c.e.c. for routine plasma 
analysis is adequate but the present g.c.m.s. (e.i. and 
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I 2 3 4 5 
2, 
m 
0)  
Standard ( p g  rnl-') c -
t Figure 6. Standard calibration curve for 1, l a  and Ib in monkey 
ing. Variable amounts of 1, l a  and l b  and 5 p g  mlF' of internal 
standard were added to monkey plasma as in Fig. 5. Methane was 
c 
plasma using chemical ionization (methane) selected ion record- .% 
d 
- 
c 
0 - 
the reactant gas with a pressure of 380p. The y-axis represents 
the ratio of areas of the monitored fragments. The x-axis 
represents the amount of drug added to monkey plasma which 
was extracted and derivatized. The final volume of extracted 
ethyl acetate was 50 @I, of which 1 pI was injected. Hence, 1/50 
of the total amount was analyzed. Note that 5 ng can easily be 
detected. About 0.5 ng is the limit of sensitivity. 
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Scon no. 
Figure 7. Mass fragmentogram of 1, l a  and Ib extracte8- ..om 
monkey plasma using e.i. The o-Br analog of ketamine was 
added to monkey plasma in a concentration of 3 p g  ml-' while 
ketamine and its metabolites were added in a concentration of 
5 p g  ml-'. One pI of the extracted and derivatized sample (20 p1 
total volume) was injected. hence, 150 and 250ng total were 
analyzed at the a.m.u. noted. Although the quantitativedata were 
obtained from m/e 102 and 210, thetwo metabolites of ketamine 
were also monitored at mle 314and 356forfurther identification. 
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Figure 8. Mass framentogram of 1, l a  and Ib extracted from 
monkey plasma using methane c.i. All compounds were added to 
monkey plasma in a concentration of 5 pg  ml-', extracted and 
derivatized. One pI of the extracted and derivatized sample (50 pl 
total volume) was injected. Hence, 100 ng of each were injected. 
The [M+H]' ions m/e 418, 420, 434, 478 as well as the ion 
fragments m/e 205, 207 and 250 were monitored. For quantita- 
tivedata ion fragments mle 205,251,420,434 and 478 were used. 
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